Technology & Psychiatry

Innovative digital therapeutics like CT-155 are transforming mental health treatment, targeting negative symptoms of schizophrenia and enhancing depression care. Check out this conversation with Shaheen Lakhan, MD, PhD.

US Senators have reintroduced The Access to Prescription Digital Therapeutics Act to increase access to prescription digital therapeutics and decrease barriers to care.

Online dating transforms connections but often leads to loneliness and mental health issues. How can we encourage safer, more meaningful interactions?

A retired psychiatrist has a conversation with AI about substance use disorder treatment.

The LGBTQIA+ community has faced marginalization and stereotyping in media, including video games. Let’s examine the intersection of identity, mental health, and video gaming.

Is psychiatry up to the challenge of protecting social well-being?

To be successful, telehealth visits must come as close as possible to in-person appointments. One psychiatrist shares his best practices.

Epidemiological data show that rates of anxiety, depression, self-injurious behaviors, and suicidality increased for Gen Z in significantly higher numbers than previous generations.

The relationship between social media use and mental health remains inconclusive. How can you best treat child and adolescents and guide their social media use?

Can AI innovations assist in the process of creating the next DSM? One psychiatrist explains his thoughts.

Learn how best to facilitate catatonia assessment via telepsychiatry in this 3-case example article.

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

Patients with treatment resistant obsessive-compulsive disorder and depression may now experience some relief using focused ultrasound.

Learn more about how AI can transform mental health care.

Judith Joseph, MD, MBA, shares her journey of balancing clinical work with social media mental health advocacy.

The president of the American Medical Association shares how AI can be useful to clinicians at the 2024 APA Annual Meeting.

Have you used AI in your clinical practice, research, or administration?

Exploring the intersection of psychiatry and work.

Our new column on AI in psychiatry explores the future of mental health care.

AI is evolving and changing the landscape of medicine and psychiatry. Here’s how clinicians can understand AI’s potential for psychiatry as well as its limitations.

The device is now available at 2 US clinics, with training and installation currently underway at several other locations.

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.

From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.

The ATA published these principles “to ensure trustworthy development, integration, and utilization of AI in order to maximize its potential benefits as a meaningful tool for patients and providers.”

From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.

From deep brain stimulation for treatment-resistant schizophrenia to a look at the potential trajectory of artificial intelligence in psychiatry and medicine, here are highlights from the week in Psychiatric Times.

Here’s how placing current debates within historical context can help us better understand the potential trajectory of artificial intelligence in psychiatry and medicine.

According to research, 32% of patients said they did not typically receive care via their preferred method, and nearly half (45%) did not think their clinician considered their preferences when deciding on the visit type.

What is new in research on depression?

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.